Screening for lung cancer: Are we there yet?

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 4, 2010, Pages 301-306

  Infante, Maurizio V ^a   Pedersen, Jesper H ^b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Low dose computed tomography; Lung cancer; Randomized controlled trial; Screening

Indexed keywords

CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; HUMAN; LUNG CANCER; LUNG NODULE; LUNG RESECTION; MINIMALLY INVASIVE SURGERY; REVIEW; SMOKING HABIT; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; VIDEO ASSISTED THORACOSCOPIC SURGERY; ADVERSE EFFECTS; CANCER STAGING; COST BENEFIT ANALYSIS; LUNG TUMOR; MASS SCREENING; MORTALITY; PATHOLOGY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SMOKING;

COST-BENEFIT ANALYSIS; HUMANS; LUNG NEOPLASMS; MASS SCREENING; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SMOKING; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 77953652117     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32833aa01c     Document Type: Review

References (63)

1. Silvestri GA, Alberg AJ, Ravenel J. The changing epidemiology of lung cancer with a focus on screening. BMJ 2009; 339:b3053.
2. Gu D, Kelly TN, Wu X, et al. Mortality attributable to smoking in China. N Engl J Med 2009; 360:150-159.
3. Freedman ND, Leitzmann MF, Hollenbeck AR, et al. Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol 2008; 9:649-656.
4. SEER. November 2005. http://seer.cancer.gov/statfacts/html/lungb.html?- statfacts-page=lungb.html&x=14&y=15.
5. Fontana RS, Sanderson DR, Woolner LB, et al. Lung cancer screening: the Mayo program. J Occup Med 1986; 28:746-750.
6. Kubik A, Parkin DM, Khlat M, et al. Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer 1990; 45:26-33.
7. Marcus PM, Bergstralh EJ, Zweig MH, et al. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst 2006; 98:748-756.
8. Sone S, Nakayama T, Honda T, et al. Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography. Lung Cancer 2007; 58:329-341.
9. Nawa T, Nakagawa T, Kusano S, et al. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest 2002; 122:15-20.
10. The International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006; 355:1763-1771.
11. Reich JM. A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening. Thorax 2008; 63:377-383; Review.
12. Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003; 362:593-597.
13. Bastarrika G, Garcia-Velloso MJ, Lozano MD, et al. Early lung cancer detection using spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med 2005; 171:1378-1383.
14. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year lung prospective experience. Radiology 2005; 235:259-265.
15. Veronesi G, Bellomi M, Mulshine JL, et al. Lung cancer screening with lowdose computed tomography: a noninvasive diagnostic protocol for baseline lung nodules. Lung Cancer 2008; 61:340-349.
16. Wilson DO, Weissfeld JL, Fuhrman CR, et al. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med 2008; 178:956-961.
17. Menezes RJ, Roberts HC, Paul NS, et al. Lung cancer screening using lowdose computed tomography in at-risk individuals: The Toronto experience. Lung Cancer 2010; 67:177-183.
18. Pedersen JH, Ashraf H, Dirksen A, et al. The Danish randomized lung cancer CT screening trial: overall design and results of the prevalence round. J Thorac Oncol 2009; 4:608-614.
19. Van Klaveren R, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009; 361:2221-2229.
20. Li F, Sone S, Abe H, et al. Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings. Radiology 2004; 233:793-798.
21. Marchianò A, Calabrò E, Civelli E, et al. Pulmonary nodules: volume repeatability at multidetector CT lung cancer screening. Radiology 2009; 251:919-925.
22. Wang Y, Van Klaveren RJ, van der Zaag-Loonen HJ, et al. Effect of nodule characteristics on variability of semiautomated volume measurements in pulmonary nodules detected in a lung cancer screening program. Radiology 2008; 248:625-631.
23. Infante M, Cavuto S, Lutman FR, et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 2009; 180:445-453.
24. Lopes Pegna A, Picozzi G, Mascalchi M, et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with lowdose CT. Lung Cancer 2009; 64:34-40.
25. Becker N, Delorme S, Kauczor HU. LUSI: the German component of the European trial on the efficacy of multislice-CT for the early detection of lung cancer. Onkologie 2008; 31 (Suppl):O320.
26. Van den Bergh KA, Essinj-Bot ML, Bunge EM, et al. Impact of computed tomography screening for lung cancer on participants in a randomized control trial (NELSON trial). Cancer 2008; 11:396-404.
27. Byrne MM, Weissfeld J, Roberts MS. Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening. Med Decis Making 2008; 28:917-925.
28. Mascalchi M, Belli G, Zappa M, et al. Risk-benefit analysis of X-ray exposure associated with lung cancer screening in the ITALUNG-CT trial. AJR Am J Roentgenol 2006; 187:421-429.
29. Crestanello JA, Allen MS, Jett JR, et al. Thoracic surgical operations in patients enrolled in a computed tomographic screening trial. J Thorac Cardiovasc Surg 2004; 128:254-259.
30. Kagna O, Solomonov A, Keidar Z, et al. The value of FDG-PET/CT in assessing single pulmonary nodules in patients at high risk of lung cancer. Eur J Nucl Med Mol Imaging 2009; 36:997-1004.
31. Infante M, Lutman RF, Imparato S, et al. Differential diagnosis and management of focal ground-glass opacities. Eur Respir J 2009; 33:821-827.
32. Kim TJ, Lee J-H, Lee C-T, et al. Diagnostic accuracy of CT-guided core biopsy of ground-glass opacity pulmonary lesions. AJR Am J Roentgenol 2002; 190:234-239.
33. Chirikos TN, Hazelton T, Tockman M, Clark R. Screening for lung cancer with CT: a preliminary cost-effectiveness analysis. Chest 2002; 121:1507-1514.
34. Mahadevia PJ, Fleisher LA, Frick KD, et al. Lung cancer screening with helical computed tomography in older adult smokers. A decision and cost-effectiveness analysis. JAMA 2003; 289:313-322.
35. McMahon PM, Kong CY, Johnson BE, et al. Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology 2008; 248:278-287.
36. Cassidy A, Myles JP, van Tongeren M, et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008; 98:270-276.
37. Omori H, Fujimoto K, Katoh T. Computed-tomography findings of emphysema: correlation with spirometric values. Curr Opin Pulm Med 2008; 14:110-114.
38. Camiciottoli G, Cavigli E, Grassi L, et al. Prevalence and correlates of pulmonary emphysema in smokers and former smokers. A densitometric study of participants in the ITALUNG trial. Eur Radiol 2009; 19:58-66.
39. Wilson DO, Weissfeld JL, Balkan A, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008; 178:738-744.
40. Calabrò E, Randi G, La Vecchia C, et al. Lung function predicts lung cancer risk in smokers: a tool for targeting screening programs. Eur Respir J 2010; 35:146-151.
41. Belinsky SA, Kieu C, Gentry FD, et al. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 2006; 66:3338-3344.
42. Baryshnikova E, Destro A, Infante M, et al. Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program. Clin Cancer Res 2008; 14:1913-1919.
43. De Costa D, Broodman I, Hoogsteden H, et al. Biomarker identification for early detection of lung cancer by proteomic techniques in the NELSON lung cancer screening trial. AACR Meeting Abstr 2008; 2008:3961.
44. Carozzi FM, Bisanzi S, Falini P, et al. Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: perspectives of integrated strategies for early diagnosis. Lung Cancer 2009; 44-53.
45. Li Y, Yang ZG, Chen TW, et al. Peripheral lung carcinoma: correlation of angiogenesis and first-pass perfusion parameters of 64-detector row CT. Lung Cancer 2008; 61:44-53.
46. Sozzi G, Roz L, Conte D, et al. Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study. Am J Respir Crit Care Med 2009; 179:69-74.
47. Lindell RM, Hartman TE, Swensen SJ, et al. 5-Year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size. Chest 2009; 136:1586-1595.
48. MacMahoun H, Austin JH, Gauser G, et al. Guidelines for management of small pulmonary nodules detected on CT scanning: a statement from the Fleischner Society. Radiology 2005; 237:395-400.
49. Takashima S, Maruyama Y, Hasegawa M, et al. CT findings and progression of small peripheral lung neoplasms having a replacement growth pattern. AJR Am J Roentgenol 2003; 180:817-826.
50. Yan TD, Black D, Bannon PG, et al. Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer. J Clin Oncol 2009; 27:2553-2562.
51. Rami-Porta R, Tsuboi M. Sublobar resection for lung cancer. Eur Respir J 2009; 33:426-435.
52. Arenberg D. Bronchioloalveolar Lung Cancer ACCP Evidence-Based Clinical Practice Guidelines (2nd edition). Chest 2007; 132:306S-313S. (Pubitemid 47502815)
53. Taylor KL, Cox LS, Zincke N, et al. Lung cancer screening is a teachable moment for smoking cessation. Lung Cancer 2007; 56:125-134.
54. Ashraf H, Tønnesen P, Pedersen JH, et al. Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST). Thorax 2009; 64:388-392.
55. Mindi A, Styn MA, Land SR, et al. Smoking behavior 1 year after computed tomography screening for lung cancer: effect of physician referral for abnormal CT findings. Cancer Epidemiol Biomarkers Prev 2009; 18:3484-3489.
56. Anderson C, Yip R, Henschke CI, et al. Smoking cessation and relapse during a lung cancer screening program. Cancer Epidemiol Biomarkers Prev 2009; 18:3476-3483.
57. UK Lung Cancer Screening Trial (UKLS). www.hta.ac.uk/1752.
58. Young RP, Hopkins R, Eaton TE. Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence. Postgrad Med J 2009; 85:414-421.
59. Jacobs PC, Prokop M, van der Graaf Y, et al. Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose nongated computed tomography in a high-risk population of heavy smokers. Atherosclerosis 2010; 209:455-462.
60. Kim SM, ChungMJ, Lee KS, et al. Coronary calcium screening using low-dose lung cancer screening: effectiveness of MDCT with retrospective reconstruction. AJR Am J Roentgenol 2008; 190:917-922.
61. Washko GR, Hoffman E, Reilly JJ. Radiographic evaluation of the potential lung volume reduction surgery candidate. Proc ATS 2008; 5:421-426.
62. Smith MA, Battafarano RJ, Meyers BF, et al. Prevalence of benign disease in patients undergoing resection for suspected lung cancer. Ann Thorac Surg 2006; 81:1824-1829.
63. Prosch H, Strasser G, Oschatz E, et al. Management of patients with small pulmonary nodules: a survey of radiologists, pulmonologists, and thoracic surgeons. AJR Am J Roentgenol 2006; 187:143-148.